Microwave Coagulation Therapy for lung cancer

Two patients with lung cancer were successfully treated by Percutaneous Microwave Coagulation Therapy (PMCT) under CT guided condition. Using our CT guided device, PMCT can be carried out safely and accurately. The first patient survived for 15months after PMCT. At least 7 months he stayed home with his family. The second was followed by operation. The specimen resected revealed massive necrosis within whole tumor although a few residual cancer cells were observed around peripheral bronchiole. PMCT has the advantage of cost-benefit balance and also a minimal invasiveness treatment for patients. PMCT will be a potent option for lung cancer therapy.